DE290205C - - Google Patents
Info
- Publication number
- DE290205C DE290205C DENDAT290205D DE290205DA DE290205C DE 290205 C DE290205 C DE 290205C DE NDAT290205 D DENDAT290205 D DE NDAT290205D DE 290205D A DE290205D A DE 290205DA DE 290205 C DE290205 C DE 290205C
- Authority
- DE
- Germany
- Prior art keywords
- theobromine
- chloride
- benzoyl
- acid
- alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 claims description 22
- 229960004559 theobromine Drugs 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 7
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 3
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 239000002184 metal Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 15
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 238000009835 boiling Methods 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- NHAXKHSVJBVINX-UHFFFAOYSA-N 3,7-dimethylpurine-2,6-dione;sodium Chemical compound [Na].CN1C(=O)NC(=O)C2=C1N=CN2C NHAXKHSVJBVINX-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- 229960004889 salicylic acid Drugs 0.000 description 3
- 235000002639 sodium chloride Nutrition 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- DSGKWFGEUBCEIE-UHFFFAOYSA-N (2-carbonochloridoylphenyl) acetate Chemical compound CC(=O)OC1=CC=CC=C1C(Cl)=O DSGKWFGEUBCEIE-UHFFFAOYSA-N 0.000 description 2
- KRENQXOFGDTODN-UHFFFAOYSA-N (2-carbonochloridoylphenyl) benzoate Chemical compound ClC(=O)C1=CC=CC=C1OC(=O)C1=CC=CC=C1 KRENQXOFGDTODN-UHFFFAOYSA-N 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 150000001805 chlorine compounds Chemical class 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- STBAIHUYRMIZEL-UHFFFAOYSA-N (2-carbonochloridoylphenyl) methyl carbonate Chemical compound C(=O)(OC)OC1=C(C(=O)Cl)C=CC=C1 STBAIHUYRMIZEL-UHFFFAOYSA-N 0.000 description 1
- QSOVSKMNRYAVJR-UHFFFAOYSA-N 2-benzoyloxybenzoic acid Chemical compound OC(=O)C1=CC=CC=C1OC(=O)C1=CC=CC=C1 QSOVSKMNRYAVJR-UHFFFAOYSA-N 0.000 description 1
- YSWISTPFRKANFF-UHFFFAOYSA-N 3,7-dimethylpurine-2,6-dione;lead Chemical compound [Pb].CN1C(=O)NC(=O)C2=C1N=CN2C YSWISTPFRKANFF-UHFFFAOYSA-N 0.000 description 1
- AAZPEFYUIATOSH-UHFFFAOYSA-N C(=O)(OC)C(N1C(NC(C=2N(C=NC1=2)C)=O)=O)C(C=1C(O)=CC=CC=1)=O Chemical compound C(=O)(OC)C(N1C(NC(C=2N(C=NC1=2)C)=O)=O)C(C=1C(O)=CC=CC=1)=O AAZPEFYUIATOSH-UHFFFAOYSA-N 0.000 description 1
- MYCVHAIBYCNWIT-UHFFFAOYSA-N C(C1=CC=CC=C1)(=O)C(N1C(NC(C=2N(C=NC1=2)C)=O)=O)C(C=1C(O)=CC=CC=1)=O Chemical compound C(C1=CC=CC=C1)(=O)C(N1C(NC(C=2N(C=NC1=2)C)=O)=O)C(C=1C(O)=CC=CC=1)=O MYCVHAIBYCNWIT-UHFFFAOYSA-N 0.000 description 1
- 241000282461 Canis lupus Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229960004025 sodium salicylate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/10—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE291077T |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE290205C true DE290205C (en:Method) |
Family
ID=33035741
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DENDAT291077D Active DE291077C (en:Method) | |||
| DENDAT290205D Active DE290205C (en:Method) |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DENDAT291077D Active DE291077C (en:Method) |
Country Status (1)
| Country | Link |
|---|---|
| DE (2) | DE290205C (en:Method) |
-
0
- DE DENDAT291077D patent/DE291077C/de active Active
- DE DENDAT290205D patent/DE290205C/de active Active
Also Published As
| Publication number | Publication date |
|---|---|
| DE291077C (en:Method) |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE290205C (en:Method) | ||
| AT71174B (de) | Verfahren zur Darstellung von Azidylsalizyloylderivaten des Theobromins. | |
| DE2655130C3 (de) | Eine praktisch lösungsmittelfreie Kristallform des Cefacetril-Natriumsalzes | |
| DE1795562B2 (de) | N-Chlor-lNp-phenyHthiazoMamidin) Ausscheidung aus: 1470071 | |
| DE2945387A1 (de) | Cephradinpraeparat und verfahren zur herstellung eines cephradin-injektionspraeparats | |
| DE901650C (de) | Verfahren zur Herstellung von therapeutisch wertvollen Verbindungen des p-Aminobenzolsulfonhydrazids | |
| DE236196C (en:Method) | ||
| DE673485C (de) | Verfahren zur Darstellung von 1-Ascorbinsaeure | |
| DE286854C (en:Method) | ||
| DE2263880B2 (de) | Hemisuccinate von dl-, d- oder 1-Allethrolon sowie deren Ephedrinsalze und Verfahren zur Aufspaltung von dl-Allethrolon | |
| DE351464C (de) | Verfahren zur Darstellung von Derivaten einer hydrierten 2-Phenylchinolin-4-carbonsaeure | |
| DE1543295C3 (de) | N-substituierte Anthranilsäuren, deren Salze, Verfahren zur Herstellung dieser Verbindungen und diese Verbindungen enthaltende Arzneimittel | |
| DE762123C (de) | Verfahren zur Herstellung von physiologisch wirksamen Abkoemmlingen des 2-Alkyl-1, 4-naphthochinons bzw. -hydrochinons | |
| DE305885C (en:Method) | ||
| DE929424C (de) | Verfahren zur Gewinnung von Sterinen oder ihren Additions-verbindungen aus Sterine enthaltenden Mischungen oder Loesungen | |
| DE82445C (en:Method) | ||
| DE286668C (en:Method) | ||
| DE69035C (de) | Verfahren zur Darstellung von p-Aethoxyacetylamidochinolin. (4 | |
| DE388669C (de) | Verfahren zur Herstellung eines Silbersalzes der Bordisalicylsaeure | |
| DE860065C (de) | Verfahren zur Herstellung von pharmakologisch wirksamen Substanzen aus Adrenalin, Adrenalinderivaten und adrenalinaehnlich gebauten Stoffen | |
| DE224953C (en:Method) | ||
| DE289454C (en:Method) | ||
| DE138845C (en:Method) | ||
| DE347139C (de) | Verfahren zur Darstellung von Metallverbindungen der Sulfinide | |
| DE223694C (en:Method) |